Jilin Province Huinan Changlong Bio-pharmacy Company Limited (HKG:8049)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.490
+0.040 (1.63%)
Apr 29, 2026, 2:38 PM HKT
31.05%
Market Cap 1.37B
Revenue (ttm) 1.00B
Net Income (ttm) 221.32M
Shares Out 560.25M
EPS (ttm) 0.40
PE Ratio 6.20
Forward PE n/a
Dividend 0.27 (11.14%)
Ex-Dividend Date Jun 22, 2026
Volume 92,000
Average Volume 86,800
Open 2.490
Previous Close 2.450
Day's Range 2.450 - 2.600
52-Week Range 1.700 - 2.600
Beta 0.24
RSI 70.76
Earnings Date Mar 31, 2026

About HKG:8049

Jilin Province Huinan Changlong Bio-pharmacy Company Limited manufactures and distributes Chinese medicines and pharmaceutical products in the People’s Republic of China. The company provides Edaravone injection, compound brain comfort capsules, haikun kidney capsules, cefpirome sulfate for injections, Cefpiramide for injections, anti-bone hyperplasia tablets, Lysine zinc gluconate tablets, and Qianlie Guihuang Tablets. It markets its products under the Changlong and Qing Tong brands. The company also engages in the manufacture and distribution... [Read more]

Sector Healthcare
Founded 1989
Employees 1,107
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 8049
Full Company Profile

Financial Performance

In 2025, HKG:8049's revenue was 901.87 million, an increase of 2.35% compared to the previous year's 881.16 million. Earnings were 198.88 million, an increase of 7.94%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.